FACTANKER · measured, cited, anchored official records connected

BIOGEN INC. — Net Income by Fiscal Year

19 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/3002818a-d175-43b5-8669-7acbec57e320/serie/net-income

Fiscal yearNet IncomePeriodEvidence
FY 2025$1.3B2025-01-01 – 2025-12-31evidence 0001193125-26-187303
FY 2024$1.6B2024-01-01 – 2024-12-31evidence 0001193125-26-187303
FY 2023$1.2B2023-01-01 – 2023-12-31evidence 0001193125-26-187303
FY 2022$3.0B2022-01-01 – 2022-12-31evidence 0001193125-26-187303
FY 2021$1.6B2021-01-01 – 2021-12-31evidence 0001193125-26-187303
FY 2020$4.0B2020-01-01 – 2020-12-31evidence 0000875045-21-000010
FY 2019$5.9B2019-01-01 – 2019-12-31evidence 0000875045-20-000005
FY 2018$4.4B2018-01-01 – 2018-12-31evidence 0000875045-19-000006
FY 2017$2.5B2017-01-01 – 2017-12-31evidence 0000875045-18-000005
FY 2016$3.7B2016-01-01 – 2016-12-31evidence 0000875045-17-000009
FY 2015$3.5B2015-01-01 – 2015-12-31evidence 0000875045-16-000042
FY 2014$2.9B2014-01-01 – 2014-12-31evidence 0000875045-16-000042
FY 2013$1.9B2013-01-01 – 2013-12-31evidence 0000875045-16-000042
FY 2012$1.4B2012-01-01 – 2012-12-31evidence 0000875045-13-000006
FY 2011$1.2B2011-01-01 – 2011-12-31evidence 0001193125-12-039072
FY 2010$1.0B2010-01-01 – 2010-12-31evidence 0000950123-11-009300
FY 2009$970.1M2009-01-01 – 2009-12-31evidence 0000950123-10-010528
FY 2008$783.2M2008-01-01 – 2008-12-31evidence 0000950123-10-010528
FY 2007$638.2M2007-01-01 – 2007-12-31evidence 0000950123-10-010528
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

BIOGEN INC. — all facts · Revenue · Operating Income